Green Biologics Ltd. is a biotechnology company founded in 2003, headquartered in the United Kingdom. The company focuses on uniting microbiology and chemistry to create sustainable ingredients for high-performing consumer goods and industrial products. Through their bio acetone, n-butanol, and IPA, they offer renewable alternatives to petrochemical-based commodities, catering to a range of applications such as specialty coatings, personal care, food, fragrance, home fuels, and plastics.
The company's technology and product development capabilities allow them to produce performance-driven solutions, enabling their customers to capitalize on the opportunities within the specialty chemicals market. They emphasize the importance of sustainability, aiming to reduce greenhouse gases and establish a sustainable value chain for the global economy. Their last investment, a $34.00M Debt Financing investment in January 2015, was secured from Tennenbaum Capital Partners.
Green Biologics stands at the forefront of an advancing industry, addressing the growing demand for transparency and safety by producing high-performing natural product lines. They also provide technical support to help customers bring sustainable products to market efficiently, aligning with the evolving corporate objectives of companies striving for sustainable development and procurement goals.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $34.00M | 1 |
|
21 Jan 2015 |
| Series C | $42.00M | 6 |
|
21 Jan 2015 |
| Series B | £15.40M | 5 |
|
02 Dec 2013 |
| Venture Round | £2.00M | 3 |
|
31 Jul 2013 |
| Venture Round | £3.21M | 3 |
|
16 May 2012 |
No recent news or press coverage available for Green Biologics Ltd..
We care about your data, and we'd love to use cookies make your experience better.
